AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.

Index of articles > Business > Trade Industries publications > High Tech Separations News articles > December 2000 articles
Close

Create a link to this page

Copy and paste this link tag into your Web page or blog:

<a href="http://www.accessmylibrary.com/coms2/summary_0286-9363445_ITM" title="Facts and information about Micromat II Picked for ACCORD Trial.">Micromat II Picked for ACCORD Trial.</a>
Close Set up an RSS feed that alerts you when new articles from High Tech Separations News are available.
XML Add to My Yahoo! Add to My AOL Add to Google Subscribe in NewsGator
Frequently asked questions about RSS feeds

Micromat II Picked for ACCORD Trial.

High Tech Separations News

| December 01, 2000 | COPYRIGHT 2003 BCC Research. (Hide copyright information)Copyright

Bio-Rad Laboratories, Inc. (1000 Alfred Nobel Dr., Hercules, CA 94547; Tel: 510/724-7000, Fax: 510/741-5817) says its platform for diabetes monitoring, the Micromat II HbA1c system, was selected for use in the action to control cardiovascular risk in diabetes (ACCORD) trial. The National Heart, Lung and Blood Institute (a division of the National Institute of Health) sponsors ACCORD.

The overall goal of the ACCORD trial is to address the challenge of reducing the rate of cardiovascular disease in patients with type 2 diabetes. Glycemic control, …

View articles courtesy of your local library
Related articles from newspapers, magazines, journals, and more
©2013 Gale, a part of Cengage Learning. All rights reserved. Contact us | Privacy policy | Terms and conditions

The AccessMyLibrary advertising network includes: womensforum.com GlamFamily